Heart attack study tests quick cholesterol drug for better recovery
NCT ID NCT05613426
First seen May 23, 2026 · Last updated May 23, 2026
Summary
This study looked at whether giving a fast-acting cholesterol-lowering drug (evolocumab) before emergency heart attack treatment could help the heart heal better. It involved 119 adults having a specific type of heart attack. The study was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ST-ELEVATION MYOCARDIAL INFARCTION (STEMI) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Fuwai Central China Cardiovascular Hospital
Zhengzhou, Henan, China
-
Hopeshine Minsheng Hospital of Xinzheng
Xinzheng, Henan, China
-
Kaifeng Central Hospital
Kaifeng, Henan, China
-
The People's Hospital of Changyuan
Xinxiang, Henan, China
-
The People's Hospital of Gongyi
Gongyi, Henan, China
-
The People's Hospital of Xuchang
Xuchang, Henan, China
Conditions
Explore the condition pages connected to this study.